Neurogenetics is the center of some of the most exciting translational clinical and basic research in neurology and human genetics. Many of the fundamental processes underlying neurological disorder stay elusive and/or poorly understood. Genetics and proteomics (the study of proteins produced by genes) will increase our understanding of predisposition to diseases therefore we can develop the next wave of therapies to treat neurological disorder.

Advances in genomics and technologies provide opportunities to better delineate neurological syndromes, understand neurological disease progression, and refine clinical treatments. As genetic understanding and applications for the treatment of neurological disease increase, another problem emerges: training the clinical neurologists to apply genetic analysis and the use of genomics.